Lopes Jéssica, Correia Marta, Martins Ilka, Henriques Ana Gabriela, Delgadillo Ivonne, da Cruz E Silva Odete, Nunes Alexandra
iBiMED, Departamento de Ciências Médicas, Universidade de Aveiro, Aveiro, Portugal.
Grupo de Neurociências e Sinalização, iBiMED, Departamento de Ciências Médicas, Universidade de Aveiro, Aveiro, Portugal.
J Alzheimers Dis. 2016 Apr 8;52(3):801-12. doi: 10.3233/JAD-151163.
To date, it is still difficult to perform an early and accurate diagnosis of dementia, therefore significant research has focused on finding new dementia biomarkers that can aid in this respect. There is an urgent need for non-invasive, rapid, and relatively inexpensive procedures for early diagnostics. Studies have demonstrated that of spectroscopic techniques, such as Fourier Transform Infrared Spectroscopy (FTIR) and Raman Spectroscopy could be a useful and accurate procedure to diagnose dementia. Given that several biochemical mechanisms related to neurodegeneration and dementia can lead to changes in plasma components and others peripheral body fluids; blood-based samples coupled to spectroscopic analyses can be used as a simple and less invasive approach.
迄今为止,痴呆症的早期准确诊断仍然困难,因此大量研究集中在寻找有助于此的新的痴呆症生物标志物。迫切需要用于早期诊断的非侵入性、快速且相对廉价的检测方法。研究表明,诸如傅里叶变换红外光谱(FTIR)和拉曼光谱等光谱技术可能是诊断痴呆症的一种有用且准确的方法。鉴于与神经退行性变和痴呆症相关的几种生化机制可导致血浆成分和其他外周体液发生变化;结合光谱分析的血液样本可作为一种简单且侵入性较小的方法。